Melber K - Search Results

1

A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice.

Buchmann P, Dembek C, Kuklick L, Jäger C, Tedjokusumo R, von Freyend MJ, Drebber U, Janowicz Z, Melber K, Protzer U. Buchmann P, et al. Among authors: melber k. Vaccine. 2013 Feb 6;31(8):1197-203. doi: 10.1016/j.vaccine.2012.12.074. Epub 2013 Jan 7. Vaccine. 2013. PMID: 23306359

2

Hepatitis B surface antigen (HBsAg) derived from yeast cells (Hansenula polymorpha) used to establish an influence of antigenic subtype (adw2, adr, ayw3) in measuring the immune response after vaccination.

Heijtink RA, Bergen Pv, Melber K, Janowicz ZA, Osterhaus AD. Heijtink RA, et al. Among authors: melber k. Vaccine. 2002 May 22;20(17-18):2191-6. doi: 10.1016/s0264-410x(02)00145-7. Vaccine. 2002. PMID: 12009272

3

Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses.

Debin A, Kravtzoff R, Santiago JV, Cazales L, Sperandio S, Melber K, Janowicz Z, Betbeder D, Moynier M. Debin A, et al. Among authors: melber k. Vaccine. 2002 Jun 21;20(21-22):2752-63. doi: 10.1016/s0264-410x(02)00191-3. Vaccine. 2002. PMID: 12034102

4

Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo.

Schirmbeck R, Melber K, Kuhröber A, Janowicz ZA, Reimann J. Schirmbeck R, et al. Among authors: melber k. J Immunol. 1994 Feb 1;152(3):1110-9. J Immunol. 1994. PMID: 8301120

5

High-level expression of foreign genes in Hansenula polymorpha.

Gellissen G, Janowicz ZA, Weydemann U, Melber K, Strasser AW, Hollenberg CP. Gellissen G, et al. Among authors: melber k. Biotechnol Adv. 1992;10(2):179-89. doi: 10.1016/0734-9750(92)90002-q. Biotechnol Adv. 1992. PMID: 14544533

6

Simultaneous expression of the S and L surface antigens of hepatitis B, and formation of mixed particles in the methylotrophic yeast, Hansenula polymorpha.

Janowicz ZA, Melber K, Merckelbach A, Jacobs E, Harford N, Comberbach M, Hollenberg CP. Janowicz ZA, et al. Among authors: melber k. Yeast. 1991 Jul;7(5):431-43. doi: 10.1002/yea.320070502. Yeast. 1991. PMID: 1897310

7

Heterologous protein production in yeast.

Gellissen G, Melber K, Janowicz ZA, Dahlems UM, Weydemann U, Piontek M, Strasser AW, Hollenberg CP. Gellissen G, et al. Among authors: melber k. Antonie Van Leeuwenhoek. 1992 Aug;62(1-2):79-93. doi: 10.1007/BF00584464. Antonie Van Leeuwenhoek. 1992. PMID: 1444338 Review.

8

Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens.

Schirmbeck R, Deml L, Melber K, Wolf H, Wagner R, Reimann J. Schirmbeck R, et al. Among authors: melber k. Vaccine. 1995 Jun;13(9):857-65. doi: 10.1016/0264-410x(94)00038-o. Vaccine. 1995. PMID: 7483809

9

Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implication for the pathogenesis of HBV-induced hepatitis.

Schirmbeck R, Melber K, Mertens T, Reimann J. Schirmbeck R, et al. Among authors: melber k. J Virol. 1994 Mar;68(3):1418-25. doi: 10.1128/JVI.68.3.1418-1425.1994. J Virol. 1994. PMID: 8107205 Free PMC article.

10

Breaking tolerance in hepatitis B surface antigen (HBsAg) transgenic mice by vaccination with cross-reactive, natural HBsAg variants.

Schirmbeck R, Dikopoulos N, Kwissa M, Leithäuser F, Lamberth K, Buus S, Melber K, Reimann J. Schirmbeck R, et al. Among authors: melber k. Eur J Immunol. 2003 Dec;33(12):3342-52. doi: 10.1002/eji.200324403. Eur J Immunol. 2003. PMID: 14635042 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page